| Schedule of reporting segment |
| | | | | | | | | | Three months ended June 30, 2026 | | | NeuroStar | | | Greenbrook | | | Total | Revenue | | $ | 14,677 | | $ | 26,891 | | $ | 41,568 | Cost of revenues | | | 3,312 | | | 17,033 | | | 20,345 | Segment gross profit | | $ | 11,365 | | $ | 9,858 | | $ | 21,223 | | | | | | | | | | | Significant Segment Expense | | | | | | | | | | Selling, General and Administrative | | | | | | | | | | Direct | | $ | 6,987 | | $ | 7,579 | | $ | 14,566 | | | | | | | | | | | Research and development | | | | | | | | | | Direct | | | 1,248 | | | 88 | | | 1,336 | | | | | | | | | | | Segment profit/(loss) | | $ | 3,130 | | $ | 2,191 | | $ | 5,321 | | | | | | | | | | | Unallocated expenses | | | | | | | | | | General and Administrative | | | | | | | | $ | 6,822 | Other income, net | | | | | | | | | (162) | Interest expense | | | | | | | | | 2,125 | | | | | | | | | | | Net loss | | | | | | | | $ | (3,464) | | | | | | | | | | |
| | | | | | | | | | Three months ended June 30, 2025 | | | NeuroStar | | | Greenbrook | | | Total | Revenue | | $ | 15,084 | | $ | 23,024 | | $ | 38,108 | Cost of revenues | | | 4,311 | | | 16,039 | | | 20,350 | Segment gross profit | | $ | 10,773 | | $ | 6,985 | | $ | 17,758 | | | | | | | | | | | Significant Segment Expense | | | | | | | | | | Selling, General and Administrative | | | | | | | | | | Direct | | $ | 8,888 | | $ | 7,331 | | $ | 16,219 | | | | | | | | | | | Research and development | | | | | | | | | | Direct | | | 1,739 | | | 59 | | | 1,798 | | | | | | | | | | | Segment profit/(loss) | | $ | 146 | | $ | (405) | | $ | (259) | | | | | | | | | | | Unallocated expenses | | | | | | | | | | General and Administrative | | | | | | | | $ | 7,799 | Other income, net | | | | | | | | | (188) | Interest expense | | | | | | | | | 1,969 | | | | | | | | | | | Net loss | | | | | | | | $ | (9,839) | | | | | | | | | | |
| | | | | | | | | | Six months ended June 30, 2026 | | | NeuroStar | | | Greenbrook | | | Total | Revenue | | $ | 27,602 | | $ | 48,420 | | $ | 76,022 | Cost of revenues | | | 6,170 | | | 32,475 | | | 38,645 | Segment gross profit | | $ | 21,432 | | $ | 15,945 | | $ | 37,377 | | | | | | | | | | | Significant Segment Expense | | | | | | | | | | Selling, General and Administrative | | | | | | | | | | Direct | | $ | 14,406 | | $ | 15,462 | | $ | 29,868 | | | | | | | | | | | Research and development | | | | | | | | | | Direct | | | 2,553 | | | 148 | | | 2,701 | | | | | | | | | | | Segment profit/(loss) | | $ | 4,473 | | $ | 335 | | $ | 4,808 | | | | | | | | | | | Unallocated expenses | | | | | | | | | | General and Administrative | | | | | | | | $ | 15,304 | Other income, net | | | | | | | | | (1,182) | Loss on extinguishment of debt | | | | | | | | | 539 | Interest expense | | | | | | | | | 4,391 | | | | | | | | | | | Net loss | | | | | | | | $ | (14,244) |
| | | | | | | | | | Six months ended June 30, 2025 | | | NeuroStar | | | Greenbrook | | | Total | Revenue | | $ | 28,400 | | $ | 41,683 | | $ | 70,083 | Cost of revenues | | | 7,461 | | | 29,126 | | | 36,587 | Segment gross profit | | $ | 20,939 | | $ | 12,557 | | $ | 33,496 | | | | | | | | | | | Significant Segment Expense | | | | | | | | | | Selling, General and Administrative | | | | | | | | | | Direct | | $ | 17,625 | | $ | 15,265 | | $ | 32,890 | | | | | | | | | | | Research and development | | | | | | | | | | Direct | | | 3,304 | | | 110 | | | 3,414 | | | | | | | | | | | Segment profit/(loss) | | $ | 10 | | $ | (2,818) | | $ | (2,808) | | | | | | | | | | | Unallocated expenses | | | | | | | | | | General and Administrative | | | | | | | | $ | 16,264 | Other income, net | | | | | | | | | (435) | Interest expense | | | | | | | | | 3,891 | | | | | | | | | | | Net loss | | | | | | | | $ | (22,528) |
|